Clinical Correlation of the CLSI Susceptibility Breakpoint for Piperacillin- Tazobactam against Extended-Spectrum-β-Lactamase-Producing Escherichia coli and Klebsiella Species

We assessed infections caused by extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella spp. treated with piperacillin-tazobactam to determine if the susceptibility breakpoint predicts outcome. Treatment was successful in 10 of 11 nonurinary infections from susceptible strains and in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gavin, Patrick J., Suseno, Mira T., Thomson, Richard B., Gaydos, J. Michael, Pierson, Carl L., Halstead, Diane C., Aslanzadeh, Jaber, Brecher, Stephen, Rotstein, Coleman, Brossette, Stephen E., Peterson, Lance R.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2006
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1479103/
https://ncbi.nlm.nih.gov/pubmed/16723596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00381-05
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars